102 related articles for article (PubMed ID: 20651352)
1. Cisplatin augments FAS-mediated apoptosis through lipid rafts.
Huang CR; Jin ZX; Dong L; Tong XP; Yue S; Kawanami T; Sawaki T; Sakai T; Miki M; Iwao H; Nakajima A; Masaki Y; Fukushima Y; Tanaka M; Fujita Y; Nakajima H; Okazaki T; Umehara H
Anticancer Res; 2010 Jun; 30(6):2065-71. PubMed ID: 20651352
[TBL] [Abstract][Full Text] [Related]
2. Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis.
Miyaji M; Jin ZX; Yamaoka S; Amakawa R; Fukuhara S; Sato SB; Kobayashi T; Domae N; Mimori T; Bloom ET; Okazaki T; Umehara H
J Exp Med; 2005 Jul; 202(2):249-59. PubMed ID: 16009715
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells.
Lacour S; Hammann A; Grazide S; Lagadic-Gossmann D; Athias A; Sergent O; Laurent G; Gambert P; Solary E; Dimanche-Boitrel MT
Cancer Res; 2004 May; 64(10):3593-8. PubMed ID: 15150117
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-treated murine peritoneal macrophages induce apoptosis in L929 cells: role of Fas-Fas ligand and tumor necrosis factor-tumor necrosis factor receptor 1.
Chauhan P; Sodhi A; Tarang S
Anticancer Drugs; 2007 Feb; 18(2):187-96. PubMed ID: 17159605
[TBL] [Abstract][Full Text] [Related]
5. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy.
Mollinedo F; Gajate C
Drug Resist Updat; 2006; 9(1-2):51-73. PubMed ID: 16687251
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
[TBL] [Abstract][Full Text] [Related]
7. DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation.
Huang HL; Fang LW; Lu SP; Chou CK; Luh TY; Lai MZ
Oncogene; 2003 Nov; 22(50):8168-77. PubMed ID: 14603257
[TBL] [Abstract][Full Text] [Related]
8. Lipid raft connection between extrinsic and intrinsic apoptotic pathways.
Gajate C; Gonzalez-Camacho F; Mollinedo F
Biochem Biophys Res Commun; 2009 Mar; 380(4):780-4. PubMed ID: 19338752
[TBL] [Abstract][Full Text] [Related]
9. Lipid rafts and Fas/CD95 signaling in cancer chemotherapy.
Gajate C; Mollinedo F
Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):274-83. PubMed ID: 21762074
[TBL] [Abstract][Full Text] [Related]
10. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
Spierings DC; de Vries EG; Vellenga E; de Jong S
Cell Death Differ; 2003 Jul; 10(7):808-22. PubMed ID: 12815464
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells.
Rebillard A; Jouan-Lanhouet S; Jouan E; Legembre P; Pizon M; Sergent O; Gilot D; Tekpli X; Lagadic-Gossmann D; Dimanche-Boitrel MT
Eur J Cancer; 2010 May; 46(8):1445-55. PubMed ID: 20202822
[TBL] [Abstract][Full Text] [Related]
12. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis.
Lincoln JE; Boling M; Parikh AN; Yeh Y; Gilchrist DG; Morse LS
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2172-8. PubMed ID: 16639029
[TBL] [Abstract][Full Text] [Related]
13. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation.
Yang BF; Xiao C; Li H; Yang SJ
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling.
Kamarajan P; Sun NK; Chao CC
Biochem J; 2003 Nov; 376(Pt 1):253-60. PubMed ID: 12911332
[TBL] [Abstract][Full Text] [Related]
15. Actinomycin D-mediated sensitization of AIDS-Kaposi's sarcoma cells to Fas-mediated apoptosis: involvement of the mitochondrion-dependent pathway.
Mori S; Murakami-Mori K; Nakamura S; Bonavida B
Int J Oncol; 2002 Apr; 20(4):819-26. PubMed ID: 11894131
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells.
Rebillard A; Tekpli X; Meurette O; Sergent O; LeMoigne-Muller G; Vernhet L; Gorria M; Chevanne M; Christmann M; Kaina B; Counillon L; Gulbins E; Lagadic-Gossmann D; Dimanche-Boitrel MT
Cancer Res; 2007 Aug; 67(16):7865-74. PubMed ID: 17699793
[TBL] [Abstract][Full Text] [Related]
17. Involvement of miltefosine-mediated ERK activation in glioma cell apoptosis through Fas regulation.
Tewari R; Sharma V; Koul N; Sen E
J Neurochem; 2008 Nov; 107(3):616-27. PubMed ID: 18710416
[TBL] [Abstract][Full Text] [Related]
18. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis.
Wang P; Song JH; Song DK; Zhang J; Hao C
Cell Signal; 2006 Sep; 18(9):1528-35. PubMed ID: 16442262
[TBL] [Abstract][Full Text] [Related]
19. Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells.
Kang YH; Lee KA; Ryu CJ; Lee HG; Lim JS; Park SN; Paik SG; Yoon DY
Cancer Lett; 2006 Jun; 237(1):33-44. PubMed ID: 16019139
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]